The World Health Organization (WHO) has once again included the RealStar^® Filovirus Screen RT-PCR Kit 1.0 for the detection and differentiation of Ebolavirus and Marburg virus in its Emergency Use Listing (EUL). This time for the detection of Ebola Bundibugyo virus (BDBV), reaffirming its value as a trusted diagnostic solution during public health emergencies.

On World Hepatitis Day, the global community comes together to raise awareness of viral hepatitis and its significant impact on public health. altona Diagnostics joins the global effort to increase awareness of viral hepatitis and provides access to reliable molecular diagnostics that support early detection and improved patient care.

altona Diagnostics is expanding its content with a new LinkedIn article series dedicated to key topics in molecular diagnostics. Complementing the regular LinkedIn updates, this series provides in-depth insights into current challenges, scientific developments, and diagnostic approaches for infectious diseases.

The latest Ebola (Bundibugyo virus) outbreak in the Democratic Republic of the Congo (DRC) and Uganda is becoming a major regional and international public health concern. For rapid and reliable diagnosis during active outbreaks, altona Diagnostics offers the RealStar^® Filovirus Screen RT-PCR Kit 1.0 (CE-IVD).

altona Diagnostics provides the RealStar^® Hantavirus-HPS RT-PCR Kit 1.0 (RUO), which is a reagent system, based on real-time PCR technology, for the qualitative detection of RNA specific for hantavirus causing pulmonary syndrome (HPS).

altona Diagnostics is pleased to welcome Maija Torniainen as new Head of Sales Europe. She joined the company in March 2026 and brings with her more than 20 years of experience in the molecular diagnostics industry, including extensive expertise in sales leadership, commercial operations, and organizational development.